It was not possible to detect BRAF V600E mutation in circulating cell-free DNA from patients with ameloblastoma: A diagnostic accuracy study.
Allan Vinícius Martins-de-BarrosFábio Andrey da Costa AraújoAna Maria Ipólito BarrosElenisa Glaucia Ferreira Dos SantosAdauto Gomes Barbosa NetoHelker Albuquerque Macedo da SilvaElker Lene Santos de LimaMaria Tereza Cartaxo MunizRiedel Frota Sá Nogueira NevesRômulo Oliveira de Hollanda ValenteEmanuel Dias de Oliveira E SilvaMarianne de Vasconcelos CarvalhoPublished in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2024)
Plasma-based liquid biopsy does not seem to be an accurate method for the detection of the BRAF V600E mutation in circulating circulating cell-free DNA from patients with ameloblastoma, regardless of tumor size, anatomic location, recurrence status, and other clinicopathological features.